Curasight A/S ("Curasight" or "the Company" – TICKER: CURAS), a clinical-stage radiopharmaceutical company developing first-in-class drug candidate uTREAT® targeting uPAR (urokinase-type plasminogen ...
Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review ...
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
Among patients receiving treatment for glioblastoma, PPI use is associated with worse progression-free and overall survival, a recent meta-analysis shows.
News Medical on MSN
Method developed to identify best treatment combinations for glioblastoma based on unique cellular targets
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to ...
Share on Pinterest Scientists have taken a new approach to treat brain cancer with the help of two supplements. Elena Popova/Getty Images A combination of two supplements — resveratrol and copper — ...
First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries– Investigator-Initiated (IIT) funded pancreatic and ...
A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback